Addressing the genetic/nongenetic duality in cancer with systems biology

Prakash Kulkarni; H. Steven Wiley; Herbert Levine; Herbert Sauro; Alexander Anderson; Stephen T.C. Wong; Aaron S. Meyer; Puneeth Iyengar; Kevin Corlette; Kristin Swanson; Atish Mohanty; Supriyo Bhattacharya; Amit Patel; Vinay Jain; Ravi Salgia

doi:10.1016/j.trecan.2022.12.004

Addressing the genetic/nongenetic duality in cancer with systems biology

Prakash Kulkarni, H. Steven Wiley, Herbert Levine, Herbert Sauro, Alexander Anderson, Stephen T.C. Wong, Aaron S. Meyer, Puneeth Iyengar, Kevin Corlette, Kristin Swanson, Atish Mohanty, Supriyo Bhattacharya, Amit Patel, Vinay Jain, Ravi Salgia

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The dogma that cancer is a genetic disease is being questioned. Recent findings suggest that genetic/nongenetic duality is necessary for cancer progression. A think tank organized by the Shraman Foundation's Institute for Theoretical Biology compiled key challenges and opportunities that theoreticians, experimentalists, and clinicians can explore from a systems biology perspective to provide a better understanding of the disease as well as help discover new treatment options and therapeutic strategies.

Original language	English (US)
Pages (from-to)	185-187
Number of pages	3
Journal	Trends in Cancer
Volume	9
Issue number	3
DOIs	https://doi.org/10.1016/j.trecan.2022.12.004
State	Published - Mar 2023

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.trecan.2022.12.004

Cite this

@article{35df52ad65804523aa926d52aa49b4da,

title = "Addressing the genetic/nongenetic duality in cancer with systems biology",

abstract = "The dogma that cancer is a genetic disease is being questioned. Recent findings suggest that genetic/nongenetic duality is necessary for cancer progression. A think tank organized by the Shraman Foundation's Institute for Theoretical Biology compiled key challenges and opportunities that theoreticians, experimentalists, and clinicians can explore from a systems biology perspective to provide a better understanding of the disease as well as help discover new treatment options and therapeutic strategies.",

author = "Prakash Kulkarni and Wiley, {H. Steven} and Herbert Levine and Herbert Sauro and Alexander Anderson and Wong, {Stephen T.C.} and Meyer, {Aaron S.} and Puneeth Iyengar and Kevin Corlette and Kristin Swanson and Atish Mohanty and Supriyo Bhattacharya and Amit Patel and Vinay Jain and Ravi Salgia",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2023",

month = mar,

doi = "10.1016/j.trecan.2022.12.004",

language = "English (US)",

volume = "9",

pages = "185--187",

journal = "Trends in Cancer",

issn = "2405-8033",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - Addressing the genetic/nongenetic duality in cancer with systems biology

AU - Kulkarni, Prakash

AU - Wiley, H. Steven

AU - Levine, Herbert

AU - Sauro, Herbert

AU - Anderson, Alexander

AU - Wong, Stephen T.C.

AU - Meyer, Aaron S.

AU - Iyengar, Puneeth

AU - Corlette, Kevin

AU - Swanson, Kristin

AU - Mohanty, Atish

AU - Bhattacharya, Supriyo

AU - Patel, Amit

AU - Jain, Vinay

AU - Salgia, Ravi

PY - 2023/3

Y1 - 2023/3

N2 - The dogma that cancer is a genetic disease is being questioned. Recent findings suggest that genetic/nongenetic duality is necessary for cancer progression. A think tank organized by the Shraman Foundation's Institute for Theoretical Biology compiled key challenges and opportunities that theoreticians, experimentalists, and clinicians can explore from a systems biology perspective to provide a better understanding of the disease as well as help discover new treatment options and therapeutic strategies.

AB - The dogma that cancer is a genetic disease is being questioned. Recent findings suggest that genetic/nongenetic duality is necessary for cancer progression. A think tank organized by the Shraman Foundation's Institute for Theoretical Biology compiled key challenges and opportunities that theoreticians, experimentalists, and clinicians can explore from a systems biology perspective to provide a better understanding of the disease as well as help discover new treatment options and therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=85146136263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85146136263&partnerID=8YFLogxK

U2 - 10.1016/j.trecan.2022.12.004

DO - 10.1016/j.trecan.2022.12.004

M3 - Article

C2 - 36635119

AN - SCOPUS:85146136263

SN - 2405-8033

VL - 9

SP - 185

EP - 187

JO - Trends in Cancer

JF - Trends in Cancer

IS - 3

ER -

Addressing the genetic/nongenetic duality in cancer with systems biology

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this